With Fund III’s investments, Oak HC/FT “will continue exploring new approaches to solving complex problems in our focus markets,” according to the post. “Healthcare costs will continue to escalate. Digitization of financial services will continue to proliferate.”
Oak HC/FT, which spun out of Oak Investment Partners in 2014, raised $500 million and $600 million, respectively, for its first two funds. The firm has invested in a variety of early-stage healthcare companies, including artificial intelligence-powered Olive, Medicare Advantage solution Devoted Health and virtual care company Galileo.
More articles on innovation:
How SCL Health’s Peter Kung promotes innovation among staff
OSF HealthCare’s investment arm launches 2nd $75M fund
9 healthcare startups join Kentucky accelerator
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
